Coinbase (COIN) finished 2024 with very strong business momentum as sentiment about the wider digital asset industry improved, broker JMP said in a research report on Thursday after the crypto ...

Truist Securities sees potential upside with the ongoing Phase 1/2 study of SGT-003 in Duchenne muscular dystrophy, while JMP Securities appreciates the company's expertise in transgene ...

while Truist Securities raised its price target to $43.00 due to encouraging data from a Phase 1 study. H.C. Wainwright reaffirmed a buy rating and a $40.00 price target, and JMP Securities ...

Citizens JMP analyst Roy Buchanan initiated coverage of Cidara Therapeutics (CDTX) with an Outperform rating and $46 price target Potential ...